SCHEMBL24327448

SCHEMBL24327448

Cc1ccc(F)c2c1N(S(C)(=O)=O)CC2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.36
KMT2A Q03164 6/20 0.36
HTT P42858 4/20 0.36
ALDH1A1 P00352 3/20 0.36
TSHR P16473 3/20 0.36
LMNA P02545 3/20 0.36
MAPT P10636 2/20 0.36
POLB P06746 2/20 0.36
GAA P10253 1/20 0.36
HTR2C P28335 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
NPBWR1 P48145 1/20 0.33
MCHR1 Q99705 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33
MAPK1 P28482 2/20 0.33
NOTUM Q6P988 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24326976 0.86 HTR2C (0.38) MEN1KMT2AHTTALDH1A1LMNA
SCHEMBL24326968 0.81 HTR2C (0.35) MEN1KMT2AALDH1A1LMNAPOLB
SCHEMBL24326971 0.81 NPSR1 (0.37) MEN1KMT2AALDH1A1LMNAMAPT
SCHEMBL24351819 0.80 HTR2A (0.39) MEN1KMT2ALMNAMAPTHTR2C
SCHEMBL24351831 0.79 HTR2C (0.40) MEN1KMT2ALMNAMAPTPOLB
SCHEMBL24326972 0.78 HTR2C (0.40) MEN1KMT2AHTTALDH1A1TSHR
SCHEMBL24351816 0.78 KDM4E (0.34) MEN1KMT2ALMNAPOLBHTR2C
SCHEMBL24351832 0.77 HTR6 (0.41) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL14591313 0.70 ALOX12 (0.47) MEN1KMT2AHTTALDH1A1LMNA
SCHEMBL24326969 0.68 MAPT (0.38) MEN1KMT2AMAPTPOLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022068849-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF EGFR AND RELATED METHODS OF USE BEIGENE, LTD. (KY) 2022-04-07 WO disclosed
WO-2022063106-A1 INDOLINE COMPOUNDS AND DERIVATIVES AS EGFR INHIBITORS BEIGENE, LTD. (KY) 2022-03-31 WO disclosed